AND017 not checked

Kind Pharmaceuticals LLC

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
6 active
10 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“AND017 capsules administered orally with a starting dose of 10 mg TIW”In the company’s words, NCT07494409 on ClinicalTrials.gov
Tested for
Anemia Due to Chronic Kidney Disease (2 trials), β -Thalassemia, Myelodysplastic Syndromes, Chemotherapy Induced Anemia, Cancer-Related Anemia
Main trialPhase 3
“This is a phase III, randomized, open-label, active-controlled study to evaluate the safety and efficacy of AND017 in anemic patients with End-Stage-Kidney-Disease (ESKD)”In the company’s words, NCT07494409 on ClinicalTrials.gov

Other drugs for Anemia Due to Chronic Kidney Disease

All 93 drugs for Anemia Due to Chronic Kidney Disease

Coming up6

Changes3

Last 90 days

Trials10

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting 20 Feb 2027 A Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With Anemia
Phase 3Recruiting 1 Mar 2027 A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD)
Phase 2Recruiting Dec 2026 A Study of Safety and Efficiency of AND017 in Patients With β-thalassemia
Phase 2Recruiting Dec 2026 A Study of Efficacy and Safety of AND017 in Patients With Myelodysplastic Syndrome
Phase 2Not yet recruiting Dec 2027 A Study of AND017 in Cancer Related Anemic Patients Receiving Chemotherapy
Phase 2Not yet recruiting May 2028 A Study of AND017 to Treat Cancer Related Anemia in Patients Not Receiving Chemotherapy
Phase 2Completed 5 Jul 2023 A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients
Phase 2Completed 29 Feb 2024 A Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on Dialysis
Phase 1Completed 11 Feb 2019 A Dose-escalation Study of AND017 in Healthy Subjects
Phase 1Completed 16 Aug 2020 A Food-Effect Study of AND017 in Healthy Participants
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow AND017

Following is part of Solo: you see every change to AND017 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in